A systematic review of clinicians' views and experiences of direct-acting oral anticoagulants in the management of nonvalvular atrial fibrillation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review of clinicians' views and experiences of direct-acting oral anticoagulants in the management of nonvalvular atrial fibrillation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-16
DOI
10.1111/bcp.13739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Patient values and preferences for antithrombotic therapy in atrial fibrillation
- (2017) Angela Ji et al. THROMBOSIS AND HAEMOSTASIS
- Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention
- (2016) Jason G. Andrade et al. CANADIAN JOURNAL OF CARDIOLOGY
- An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harm
- (2016) A. Olaiya et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Direct new oral anticoagulants: follow-up, guidelines and bleeding complications in general practice—a survey of Swiss general internal medicine practitioners
- (2016) Thomas C. Sauter et al. SpringerPlus
- Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey
- (2015) T. B. Larsen et al. EUROPACE
- Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives
- (2015) Antonio Gómez-Outes et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
- (2015) G. D. Barnes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Perioperative Management of Patients Receiving New Oral Anticoagulants
- (2014) David Faraoni et al. CLINICS IN LABORATORY MEDICINE
- Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey
- (2014) T. S. Potpara et al. EUROPACE
- The use of direct oral anticoagulants for stroke prevention in atrial fibrillation: A study on physicians' perspective and preferences
- (2014) Alexander Wutzler et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey
- (2013) G. Y. H. Lip et al. EUROPACE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started